ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,711,826 | -26.5% | 116,514 | -15.5% | 0.49% | -47.0% |
| Q4 2022 | $6,411,107 | +0.5% | 137,814 | +12.0% | 0.92% | +6.1% |
| Q3 2022 | $6,381,000 | +35.0% | 123,014 | +23.0% | 0.87% | +17.6% |
| Q2 2022 | $4,727,000 | -67.2% | 100,000 | -50.6% | 0.74% | -60.4% |
| Q1 2022 | $14,413,000 | -39.4% | 202,485 | -36.4% | 1.86% | -22.0% |
| Q4 2021 | $23,801,000 | +129.7% | 318,275 | +74.5% | 2.38% | +47.6% |
| Q3 2021 | $10,362,000 | +1870.0% | 182,400 | +1486.1% | 1.62% | +478.9% |
| Q3 2020 | $526,000 | -8.8% | 11,500 | 0.0% | 0.28% | -15.2% |
| Q2 2020 | $577,000 | +5.9% | 11,500 | +8.5% | 0.33% | -48.1% |
| Q1 2020 | $545,000 | – | 10,600 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |